The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial by Lerman C, Wileyto E P, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields P G, Kaufmann V, Redden D, Benowitz N, Berrettini W H in The pharmacogenomics journal (2004).

[PMID: 15007373] PubMed


Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Rx Annotations

No dosing information annotated.